Literature DB >> 35670824

Network pharmacology approach and molecular docking to explore the potential mechanism of Wu-Wei-Wen-Tong Chubi capsules in rheumatoid arthritis.

Xiaoya Cui1,2, Jian Liu1,3,4, Lili Zhang1,2, Xiaoli Wang2, Xiaochuang Liu1, Hui Jiang5,6,7,8.   

Abstract

Network pharmacology, a holistic approach based on the theory of biological network technology, integrates information from biological systems, drugs, and diseases. Here, this theory was used to predict the targets of Wu-Wei-Wen-Tong Chubi capsule (WWWT) to explore the mechanism in the treatment of rheumatoid arthritis (RA). The ingredients of each herbal medicine in WWWT were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), and the active ingredients were screened through bioavailability (OB) ≥30% and drug-likeness (DL) ≥ 0.18. SwissTargetPrection and TCMSP were utilized to calculate and predict the targets of active ingredients. RA-related targets were obtained by searching the Genecards and OMIM databases. The common targets of RA and WWWT were used for gene ontology (GO), KEGG pathway enrichment, protein-protein interaction (PPI) analysis, and molecular docking. And then, four key genes were screened for subsequent verification experiments. In total, 90 active compounds and 330 potential targets of WWWT, 1310 targets of RA, and 135 intersection targets were found. Additionally, GO and pathway analysis identified 4610 significant GO terms and 147 significant KEGG pathways. Based on the PPI network, 11 key genes including IL-6, MMP-9, and TNF-α were screened out for molecular docking. Molecular docking showed that these key genes have good binding activities to active compounds of WWWT such as oroxylin a, kaempferol, and luteolin. Simultaneously, Western blot experimental validation demonstrated that the protein expressions of IL-6, MMP-9, TNF-α, and VEGFA significantly decreased after WWWT treatment. The mechanism of WWWT in treating RA involves multiple active compounds acting on multiple targets, and multiple pathways, which provides an important reference for further elucidation the mechanism and clinical applications of WWWT in the treatment of RA.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Wu-Wei-Wen-Tong Chubi capsule; molecular docking; network pharmacology; rheumatoid arthritis

Mesh:

Substances:

Year:  2022        PMID: 35670824     DOI: 10.1007/s00210-022-02260-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.195


  37 in total

Review 1.  Network pharmacology: the next paradigm in drug discovery.

Authors:  Andrew L Hopkins
Journal:  Nat Chem Biol       Date:  2008-11       Impact factor: 15.040

2.  Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis.

Authors:  Qiyuan An; Wenkai Yan; Yi Zhao; Keqiang Yu
Journal:  Int Immunopharmacol       Date:  2018-10-09       Impact factor: 4.932

3.  Proliferation of rheumatoid arthritis fibroblast-like synoviocytes is enhanced by IL-17-mediated autophagy through STAT3 activation.

Authors:  Le Chang; Xin Feng; Wei Gao
Journal:  Connect Tissue Res       Date:  2018-12-04       Impact factor: 3.417

4.  SwissTargetPrediction: a web server for target prediction of bioactive small molecules.

Authors:  David Gfeller; Aurélien Grosdidier; Matthias Wirth; Antoine Daina; Olivier Michielin; Vincent Zoete
Journal:  Nucleic Acids Res       Date:  2014-05-03       Impact factor: 16.971

5.  A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis.

Authors:  Xiang Guo; Jinyu Ji; Zhitao Feng; Xiaoqiang Hou; Yanan Luo; Zhigang Mei
Journal:  Int Immunopharmacol       Date:  2020-01-20       Impact factor: 4.932

6.  A Network Pharmacology Study on the Active Ingredients and Potential Targets of Tripterygium wilfordii Hook for Treatment of Rheumatoid Arthritis.

Authors:  Wei Hu; Wanjin Fu; Xin Wei; Yang Yang; Chao Lu; Zeyuan Liu
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-15       Impact factor: 2.629

7.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.

Authors:  Antoine Daina; Olivier Michielin; Vincent Zoete
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

Review 8.  C-type lectins in immunity and homeostasis.

Authors:  Gordon D Brown; Janet A Willment; Lauren Whitehead
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

9.  Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Shan-Shan Gao; Ji-Jia Sun; Xin Wang; Yi-Yang Hu; Qin Feng; Xiao-Jun Gou
Journal:  Biomed Res Int       Date:  2020-11-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.